|
|
|
|
Vol. 59, Issue 5, 1225-1234, May 2001
1C/A-Adrenergic
Receptor Gene and Analysis of an
1C Promoter in Cardiac Myocytes:
Role of an MCAT Element That Binds Transcriptional Enhancer Factor-1
(TEF-1)
Cardiology Division and Research Service, Veterans Affairs Medical
Center, San Francisco, California; and the Cardiovascular Research
Institute and Department of Medicine, University of California, San
Francisco, California
1-Adrenergic receptor (AR) subtypes in the heart are expressed
by myocytes but not by fibroblasts, a feature that distinguishes
1-ARs from
-ARs. Here we studied myocyte-specific expression of
1-ARs, focusing on the subtype
1C (also called
1A), a subtype implicated in cardiac hypertrophic signaling in rat models. We first
cloned the mouse
1C-AR gene, which consisted of two exons with an 18 kb intron, similar to the
1B-AR gene. The receptor coding sequence
was >90% homologous to that of rat and human.
1C-AR transcription
in mouse heart was initiated from a single Inr consensus sequence at
588 from the ATG; this and a putative polyadenylation sequence 8.5 kb
3' could account for the predominant 11 kb
1C mRNA in mouse heart. A
5'-nontranscribed fragment of 4.4 kb was active as a promoter in
cardiac myocytes but not in fibroblasts. Promoter activity in myocytes
required a single muscle CAT (MCAT) element, and this MCAT bound in
vitro to recombinant and endogenous transcriptional enhancer
factor-1. Thus,
1C-AR transcription in cardiac myocytes
shares MCAT dependence with other cardiac-specific genes, including the
- and
-myosin heavy chains, skeletal
-actin, and brain
natriuretic peptide. However, the mouse
1C gene was not transcribed
in the neonatal heart and was not activated by
1-AR and other
hypertrophic agonists in rat myocytes, and thus differed from other
MCAT-dependent genes and the rat
1C gene.
This article has been cited by other articles:
![]() |
T. Yoshida MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 8 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Michelotti, D. M. Brinkley, D. P. Morris, M. P. Smith, R. J. Louie, and D. A. Schwinn Epigenetic regulation of human {alpha}1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation FASEB J, July 1, 2007; 21(9): 1979 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Rorabaugh, S. A. Ross, R. J. Gaivin, R. S. Papay, D. F. McCune, P. C. Simpson, and D. M. Perez {alpha}1A- but not {alpha}1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism Cardiovasc Res, February 1, 2005; 65(2): 436 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Michelotti, M. J. Bauman, M. P. Smith, and D. A. Schwinn Cloning and Characterization of the Rat alpha 1a-Adrenergic Receptor Gene Promoter. DEMONSTRATION OF CELL SPECIFICITY AND REGULATION BY HYPOXIA J. Biol. Chem., February 28, 2003; 278(10): 8693 - 8705. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Rokosh and P. C. Simpson Knockout of the alpha 1A/C-adrenergic receptor subtype: The alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure PNAS, July 9, 2002; 99(14): 9474 - 9479. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||